Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-05-16Clinical Trial Update: Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)
Observational study evaluating outcomes of biological treatments in rheumatoid arthritis, completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Exercise Perceptions and Preferences Among Rheumatoid Arthritis Patients
The completed clinical trial update examines exercise perceptions and preferences among patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis [Phase 4]
This is a Phase 4 trial update evaluating low-dose rituximab as a first-line biologic therapy for DMARD-resistant rheumatoid arthritis. The …
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: Optimization of Treatment With Adalimumab (Humira)
A completed clinical trial update on optimizing treatment with adalimumab (Humira) for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty [NA]
The completed trial assessed the efficacy of the Aquamantys device in reducing transfusions during anterior supine intermuscular approach to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy [Phase 4]
Open-label Phase 4 trial comparing etanercept to conventional DMARD therapy in rheumatoid arthritis. Results were posted on 2012-04-19.
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403 [Phase 2]
Phase 2 trial update reporting long-term efficacy and safety of repeated courses of ofatumumab in rheumatoid arthritis patients previously t…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs) [Phase 3]
Phase 3 clinical trial evaluating tocilizumab for moderate-to-severe rheumatoid arthritis in patients with inadequate response to or intoler…
-
FDA approval · 2012-04-17FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc.
-
CLINICAL_TRIALS research · 2012-04-13Clinical Trial Update: Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics
A completed observational real-world study evaluating the cost of infections in rheumatoid arthritis patients treated with biologics.
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate [Phase 1]
A Phase 1b clinical trial evaluating PLX5622 in rheumatoid arthritis patients receiving methotrexate has completed, reporting the trial stat…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial evaluating adalimumab in Japanese patients with rheumatoid arthritis has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: Dose Escalation With Remicade® and Orencia®
Clinical trial update reporting completion of a dose-escalation study combining Remicade and Orencia for rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2012-03-29Clinical Trial Update: Application of EULAR Recommendations for Cardiovascular Risk Management in Patients With Rheumatoid Arthritis
This study evaluates how to apply EULAR recommendations for cardiovascular risk management in patients with rheumatoid arthritis. It aims to…
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating tacrolimus plus methotrexate versus placebo plus methotrexate for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Phase IIIB Switching From Intravenous to Subcutaneous Study [Phase 3]
Phase IIIB study evaluating switching from intravenous to subcutaneous abatacept (Orencia) in rheumatoid arthritis completed; results posted…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System [NA]
A completed clinical trial evaluating the LCS Complete Posterior Stabilized Mobile-bearing Total Knee System by DePuy Orthopaedics, with res…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis [NA]
A completed clinical trial evaluating TNF-alpha inhibitor therapy in TNF-alpha–naive patients with poor-prognosis rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Dosing Flexibility Study in Patients With Rheumatoid Arthritis [Phase 4]
A Phase 4 study evaluating dosing flexibility in patients with rheumatoid arthritis has completed and results posted.
-
FDA approval · 2012-03-15FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps containing naproxen sodium, expanding the approval to include a new dosage form…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Rheumatoid Foot Insole [NA]
This document provides an update on a clinical trial evaluating a rheumatoid foot insole for rheumatoid arthritis, with the current status l…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 study of MTRX1011A in rheumatoid arthritis evaluating safety, pharmacokinetics, and pharmacodynamics was terminated.
-
FDA approval · 2012-03-05FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)
FDA approved a supplemental application for ZYBIC (meloxicam) submitted by Redmont Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating SC12267 (4SC-101) in combination with methotrexate for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS research · 2012-02-24Clinical Trial Update: Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement
A clinical trial update evaluating whether adding a TNF-inhibitor to conventional DMARD therapy affects cervical pannus in rheumatoid arthri…